Page 928 - Adams and Stashak's Lameness in Horses, 7th Edition

894 Chapter 8

Joint Disease in the Horse. Philadelphia, PA, WB Saunders, 86. Narins RS, Coleman WP, Rohrich R, et al. 12‐Month controlled
1996;257–269. study in the United States of the safety and efficacy of a perma-
VetBooks.ir 65. Kawcak CE, Trotter G. Other joint conditions. In Ross M, Dyson 87. Pacini S, Spinabella S, Trombi L, et al. Suspension of bone mar-
64. Indrawattana N, Chen G, Tadokoro M, et al. Growth factor com-
nent 2.5% polyacrylamide hydrogel soft‐tissue filler. Dermatol
Surg 2010;36(Suppl 3):1819–1829.
bination for chondrogenic induction from human mesenchymal
stem cell. Biochem Biophys Res Commun 2004;320:914–919.
row‐derived undifferentiated mesenchymal stromal cells for
SJ, eds. Diagnosis and Management of Lameness in the Horse.
Saunders, Philadelphia, 2003;610–613. repair of superficial digital flexor tendon in race horses. Tissue
Eng 2007;13(12):2949–2955.
66. Kawcak CE, Norrdin RW, Frisbie DD, et al. Effects of osteochon- 88. Pallua N, Wolter TP. A 5‐year assessment of safety and aesthetic
dral fragmentation and intra‐articular triamcinolone acetonide results after facial soft‐tissue augmentation with polyacrylamide
treatment on subchondral bone in the equine carpus. Equine Vet J hydrogel (Aquamid): a prospective multicenter study of 251
1998;30(1):66–71. patients. Plast Reconstr Surg 2010;125(6):1797–1804.
67. Kay A, Bolt DM, Ishihara A, et al. Anti‐inflammatory and analge- 89. Pelletier J, Martel‐Pelletier J. Protective effects of corticosteroids
sic effects of intra‐articular injection of triamcinolone acetonide, on cartilage lesions and osteophyte formation in the Pond‐Nuki
mepivacaine hydrochloride, or both on lipopolysaccharide‐induced model of osteoarthritis. Arthritis Rheum 1989;32:181–193.
lameness in horses. Am J Vet Res 2008;69(12):1646–1654. 90. Peyron JG. A new approach to the treatment of osteoarthritis: vis-
68. Kilborne A, Hussein H, Bertone A. Effects of hyaluronan alone or cosupplementation. Osteoarthritis Cartilage 1993;1(2):85–87.
in combination with chondroitin sulfate and N‐acetyl‐d‐glucosa- 91. Pichereau F, Décory M, Cuevas Ramos G. Autologous platelet
mine on lipopolysaccharide challenge‐exposed equine fibroblast‐ concentrate as a treatment for horses with refractory fetlock
like synovial cells. Am J Vet Res 2017;78(5):579–588. osteoarthritis. J Equine Vet Sci 2014;34(4):489–493.
69. Knych HK, Stanley SD, Harrison LM, et al. Pharmacokinetics of 92. Pisko E, Turner R, Soderstrom L, et al. Inhibition of neutrophil
betamethasone in plasma, urine, and synovial fluid following phagocytosis and enzyme release by hyaluronic acid. Clin Exp
intra‐articular administration to exercised thoroughbred horses. Rheumatol 1983;1:41–44.
Drug Test Anal 2017;9(9):1385–1391. 93. Polysulfated Glycosaminoglycan, 21 C.F.R. §522.1850;2019.
70. Knych HK, Vidal MA, Chouicha N, et al. Cytokine, catabolic 94. Pourcho Adam M, Smith Jay J, Wisniewski Stephen L, et al.
enzyme and structural matrix gene expression in synovial fluid Intraarticular platelet‐rich plasma injection in the treatment of
following intra‐articular administration of triamcinolone aceton- knee osteoarthritis: review and recommendations. Am J Phys
ide in exercised horses. Equine Vet J 2017;49(1):107–115. Med Rehabil 2014;93(11 Suppl 3):S108–S121.
71. Kon E, Buda R, Filardo G, et al. Platelet‐rich plasma: intra‐ articular 95. Prehm P. Hyaluronate is synthesized at plasma membranes.
knee injections produced favorable results on degenerative Biochem J 1984;220(2):597.
cartilage lesions. Knee Surg Sport Traumatol Arthrosc 2010;18(4): 96. Randelli P, Arrigoni P, Ragone V, et al. Platelet rich plasma in
472–479. arthroscopic rotator cuff repair: a prospective RCT study, 2‐year
72. Kon E, Engebretsen L, Verdonk P, et al. Clinical outcomes of knee follow‐up. J Shoulder Elb Surg 2011;20(4):518–528.
osteoarthritis treated with an autologous protein solution injec- 97. Richardson DW, Dodge GR. Dose‐dependent effects of corticos-
tion: a 1‐year pilot double‐blinded randomized controlled trial. teroids on the expression of matrix‐related genes in normal and
Am J Sports Med 2018;46(1):171–180. cytokine‐treated articular chondrocytes. Inflamm Res 2003;
73. Kristiansen KK, Kold SE. Multivariable analysis of factors influ- 52(1):39–49.
encing outcome of 2 treatment protocols in 128 cases of horses 98. Rose RJ. The intra‐articular use of sodium hyaluronate for the
responding positively to intra‐articular analgesia of the distal treatment of osteo‐arthrosis in the horse. NZ Vet J 1979;27:5–8.
interphalangeal joint. Equine Vet J 2007;39(2):150–156. 99. Rydell N. Decreased granulation tissue reaction after installment
74. Labens R, Voûte LC, Mellor DJ. Retrospective study of the effect of hyaluronic acid. Acta Orthop Scand 1970;41(3):307.
of intra‐articular treatment of osteoarthritis of the distal tarsal 100. Sampson S, Botto‐van Bemden A, Aufiero D. Autologous
joints in 51 horses. Vet Rec 2007;161(18):611. bone marrow concentrate: review and application of a novel
75. Leardini G, Mattara L, Franceschini M, et al. Intra‐articular treat- intra‐articular orthobiologic for cartilage disease. Phys Sport
ment of knee osteoarthritis. A comparative study between hyalu- 2013;41(3):7–18.
ronic acid and 6‐methyl prednisolone acetate. Clin Exp Rheumatol 101. Sandow C, Aguilar C, Riggs L. Evaluation of the short‐term
1991;9:375–381. effects of intra‐articular administration of platelet‐rich plasma in
76. Lynch T, Caron J, Arnoczky S, et al. Influence of exogenous hyalu- horses with experimentally induced synovitis. Vet Comp Orthop
ronan on synthesis of hyaluronan and collagenase by equine syn- Traumatol 2018;31(S02):A1–A25.
oviocytes. Am J Vet Res 1998;59:888–892. 102. Schnabel L, Mohammed H, Miller B, et al. Platelet rich plasma
77. Macleod J, Fubini S, Gu D, et al. Effect of synovitis and corticos- (PRP) enhances anabolic gene expression patterns in flexor digi-
teroids on transcription of cartilage matrix proteins. Am J Vet Res torium superficialis tendons. J Orthop Res 2007;25:230–240.
1998;59:1021–1026. 103. Silberberg M, Silberberg R, Hasler M. Fine structure of articular
78. McCarty O. Glucocorticoids. In McCarty O, ed. Arthritis and cartilage in mice receiving cortisone acetate. Arch Pathol
Allied Conditions. Lea & Febiger, Philadelphia, 1989;604–621. 1966;82:569–582.
79. Mcclure SR, Wang C. A preliminary field trial evaluating the effi- 104. Smit Y, Goddard A, Mahne A, et al. Clinical signs, synovial fluid
cacy of 4% polyacrylamide hydrogel in horses with osteoarthritis. cytology and growth factor concentrations after intra‐articular
J Equine Vet Sci 2017;54:98–102. use of a platelet‐rich product in horses with osteoarthritis.
80. Mccluskey MJ, Kavenagh PB. Clinical use of triamcinolone aceto- Equine Vet J 2016;48:29–29.
nide in the horse (205 cases) and the incidence of glucocorticoid‐ 105. Smith LCR, Wylie CE, Palmer L, et al. A longitudinal study of
induced laminitis associated with its use. Equine Vet Educ fractures in 1488 Thoroughbred racehorses receiving intrasyno-
2004;16(2):86–89. vial medication: 2006–2011. Equine Vet J 2018;50(6):774–780.
81. Mcdougall JJ, Elenko RDV, Bray RC. Cholinergic vasoregulation doi:10.1111/evj.12833.
in normal and adjuvant monoarthritic rat knee joints. J Auton 106. Steel C, Pannirselvam R, Anderson G. Risk of septic arthritis
Nerv Syst 1998;72(1):55–60. after intra‐articular medication: a study of 16,624 injections in
82. Meijer H, Reinecke J, Becker C, et al. The production of anti‐ Thoroughbred racehorses. Aust Vet J 2013;91(7):268–273.
inflammatory cytokines in whole blood by physico‐chemical 107. Textor JA, Tablin F. Intra‐articular use of a platelet‐rich product
induction. Inflamm Res 2003;52(10):404–407. in normal horses: clinical signs and cytologic response. Vet Surg
83. Moraes APL, Moreira JJ, Brossi PM, et al. Short‐ and long‐term 2013;42(5):499–510.
effects of platelet‐rich plasma upon healthy equine joints: clinical 108. Tnibar A, Schougaard H, Koene M, et al. A controlled clinical
and laboratory aspects. Can Vet J 2015;56(8):831–838. trial on the efficacy of an intra‐articular polyacrylamide hydrogel
84. Murphy DJ, Todhunter RJ, Fubini SL, et al. The effects of methyl- in horses with osteoarthritis [abstract]. Vet Surg 2014;43(5):s138.
prednisolone on normal and monocyte‐conditioned medium‐ 109. Tnibar A, Schougaard H, Camitz L, et al. An international multi‐
treated articular cartilage from dogs and horses. Vet Surg centre prospective study on the efficacy of an intraarticular poly-
2000;29(6):546–557. acrylamide hydrogel in horses with osteoarthritis: a 24 months
85. Murray RC, Znaor N, Tanner KE, et al. The effect of intra‐articu- follow‐up. Acta Vet Scand 2015;57(1):20.
lar methylprednisolone acetate and exercise on equine carpal sub- 110. Todhunter R, Lust G. Polysulfated glycosaminoglycan in the
chondral and cancellous bone microhardness. Equine Vet J treatment of osteoarthritis. J Am Vet Med Assoc 1994;204:
2002;34(3):306. 1245–1251.